Details for New Drug Application (NDA): 203730
✉ Email this page to a colleague
The generic ingredient in DIVALPROEX SODIUM is divalproex sodium. There are eighteen drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the divalproex sodium profile page.
Summary for 203730
| Tradename: | DIVALPROEX SODIUM |
| Applicant: | Amneal Pharms |
| Ingredient: | divalproex sodium |
| Patents: | 0 |
Pharmacology for NDA: 203730
| Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 203730
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DIVALPROEX SODIUM | divalproex sodium | TABLET, EXTENDED RELEASE;ORAL | 203730 | ANDA | Major Pharmaceuticals | 0904-7182 | 0904-7182-45 | 80 BLISTER PACK in 1 CARTON (0904-7182-45) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
| DIVALPROEX SODIUM | divalproex sodium | TABLET, EXTENDED RELEASE;ORAL | 203730 | ANDA | Major Pharmaceuticals | 0904-7182 | 0904-7182-61 | 100 BLISTER PACK in 1 CARTON (0904-7182-61) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 250MG VALPROIC ACID | ||||
| Approval Date: | May 29, 2015 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 500MG VALPROIC ACID | ||||
| Approval Date: | May 29, 2015 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
